Basel Medical
BMGL
6 hedge funds and large institutions have $221K invested in Basel Medical in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.06% more ownership
Funds ownership: 0% → 0.06% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$314K |
| 2 |
VF
Virtu Financial
New York
|
+$59.3K |
| 3 |
MG
Marex Group
London,
|
+$51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
| 5 |
Barclays
London,
United Kingdom
|
+$5.72K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $152K | +$314K | +7,133 | New |
|
|
VF
2
Virtu Financial
New York
| $29K | +$59.3K | +1,348 | New |
|
|
MG
3
Marex Group
London,
| $24.8K | +$51K | +1,160 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $10K | +$20.7K | +470 | New |
|
|
5
Barclays
London,
United Kingdom
| $2.78K | +$5.72K | +130 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $2.57K | +$5.28K | +120 | New |
|
BMGL Hedge Fund Activity: Q2 2025 in Review
6 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q2 2025, worth a combined $221K.
Buyers outnumbered sellers: 6 funds opened new BMGL positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $314K.
- 6 institutional investors held Basel Medical (BMGL) as of Q2 2025, up from 0 in Q1 2025.
- Funds reported $221K of Basel Medical stock for Q2 2025.
- 6 funds opened new Basel Medical positions in Q2 2025 and 0 closed out, a net change of +6 holders.
- The largest Basel Medical buyer in Q2 2025 was HRT Financial, an estimated $314K added.
Based on aggregated 13F filings for Q2 2025.